← FDA Drug Approvals (Drugs@FDA)

SPIRONOLACTONE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA · Approved 2014-03-06

Drug application

FDA Application #

ANDA202187

Application type

Abbreviated New Drug Application (Generic)

Brand name

SPIRONOLACTONE

Generic name

SPIRONOLACTONE

Active ingredients

SPIRONOLACTONE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

AUROBINDO PHARMA

Manufacturer

NorthStar Rx LLC

First approval

2014-03-06

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown